ArticleEye (London, England)2024

An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.

Aurelie Meunier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.